Impacts of Neighborhood Characteristics and Surgical Treatment Disparities on Overall Mortality in Stage I Renal Cell Carcinoma Patients.
cancer health disparities
geospatial
kidney cancer
neighborhood socioeconomic status
surgical disparities
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
12 02 2022
12 02 2022
Historique:
received:
30
11
2021
revised:
15
01
2022
accepted:
09
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
22
3
2022
Statut:
epublish
Résumé
Racial/ethnic minority groups in the United States have high renal cell carcinoma (RCC) mortality rates. This study assessed surgical treatment disparities across racial/ethnic groups and impacts of neighborhood socioeconomic characteristics on surgical treatments and overall mortality. Stage I RCC patients diagnosed between 2004 and 2016 from National Cancer Database were included (n = 238,141). We assessed differences in associations between race/ethnicity and treatment patterns using logistic regression and between race/ethnicity and overall mortality using Cox regression with and without neighborhood characteristics in the regression models. When compared to non-Hispanic Whites (NHWs), American Indians/Alaska Natives and non-Hispanic Blacks (NHBs) were more likely not to receive surgical care and all racial/ethnic minority groups had significantly increased odds of undergoing radical rather than partial nephrectomy, even after adjusting for neighborhood characteristics. Including surgical treatment and neighborhood factors in the models slightly attenuated the association, but NHBs had a significantly increased risk of overall mortality. NHBs who underwent radical nephrectomy had an increased risk of mortality (HR 1.15, 95% CI: 1.08-1.23), but not for NHBs who underwent partial nephrectomy (HR 0.92, 95% CI: 0.84-1.02). Neighborhood factors were associated with surgical treatment patterns and overall mortality in both NHBs and NHWs. Neighborhood socioeconomic factors may only partly explain RCC disparities.
Identifiants
pubmed: 35206240
pii: ijerph19042050
doi: 10.3390/ijerph19042050
pmc: PMC8872003
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : U54CA143925
Pays : United States
Organisme : NCI NIH HHS
ID : U54CA143924
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA143924
Pays : United States
Organisme : NCI NIH HHS
ID : 1R21CA248361
Pays : United States
Organisme : NCI NIH HHS
ID : P30CA023074
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA248361
Pays : United States
Références
Health Aff (Millwood). 2018 Sep;37(9):1400-1408
pubmed: 30179559
JAMA Oncol. 2016 May 1;2(5):664-667
pubmed: 27010573
J Racial Ethn Health Disparities. 2017 Dec;4(6):1195-1205
pubmed: 28039602
Urol Oncol. 2017 Mar;35(3):113.e15-113.e21
pubmed: 27839926
Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):53-60
pubmed: 33008873
Clin Genitourin Cancer. 2020 Dec;18(6):e643-e650
pubmed: 32389458
BJU Int. 2013 Jun;111(8):E274-82
pubmed: 23714645
JAMA Oncol. 2016 Jan;2(1):85-93
pubmed: 26502115
J Aging Health. 2018 Jul;30(6):863-881
pubmed: 28553811
Cancer Med. 2016 Aug;5(8):2101-8
pubmed: 27228559
Urol Oncol. 2013 Nov;31(8):1794-9
pubmed: 22687567
J Clin Oncol. 2007 Aug 20;25(24):3589-95
pubmed: 17704406
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):210-7
pubmed: 25417234
Cancer Causes Control. 2019 Dec;30(12):1389-1397
pubmed: 31630307
Clin Gastroenterol Hepatol. 2019 Mar;17(4):657-665.e13
pubmed: 30036643
Clin Genitourin Cancer. 2017 Apr;15(2):203-206
pubmed: 27554583
Urology. 2019 Jan;123:167-173
pubmed: 30059717
Cancers (Basel). 2021 Feb 27;13(5):
pubmed: 33673457
Eur Urol Focus. 2019 May;5(3):482-487
pubmed: 29325761
Urology. 2016 Apr;90:69-74
pubmed: 26724412
Epidemiology. 2015 Jan;26(1):59-67
pubmed: 25393631
World J Oncol. 2020 Jun;11(3):79-87
pubmed: 32494314
J Clin Oncol. 2018 Jan 1;36(1):25-33
pubmed: 29035642
Cancer. 2013 Jan 15;119(2):388-94
pubmed: 23147245
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Hepatol Commun. 2020 Aug 12;4(11):1708-1716
pubmed: 33163839
J Clin Oncol. 2021 Sep 1;39(25):2749-2757
pubmed: 34129388
J Urol. 2021 Feb;205(2):426-433
pubmed: 33226309
Int J Urol. 2017 Oct;24(10):765-770
pubmed: 28913849
Urol Oncol. 2020 Dec;38(12):938.e9-938.e17
pubmed: 32950398
Cancer Epidemiol. 2021 Jun;72:101938
pubmed: 33862414
J Urol. 2016 Oct;196(4):1000-7
pubmed: 27113965
JAMA Surg. 2018 Sep 1;153(9):850-851
pubmed: 29617542
Ann Surg Oncol. 2019 Jun;26(6):1604-1612
pubmed: 30737668
Int J Environ Res Public Health. 2021 Sep 15;18(18):
pubmed: 34574655
Cancer Med. 2019 Nov;8(15):6780-6788
pubmed: 31509346
Semin Nephrol. 2020 Jan;40(1):59-68
pubmed: 32130967
BMC Cancer. 2011 Sep 21;11:402
pubmed: 21936934
Cancer Med. 2016 Feb;5(2):200-8
pubmed: 26710924
Curr Oncol. 2019 Apr;26(2):e216-e225
pubmed: 31043830
World J Urol. 2013 Oct;31(5):1211-7
pubmed: 22622394
Am J Public Health. 2014 Jun;104 Suppl 3:S396-403
pubmed: 24754655
Nat Rev Nephrol. 2014 Mar;10(3):135-45
pubmed: 24419566
J Racial Ethn Health Disparities. 2019 Apr;6(2):401-408
pubmed: 30506310
BMC Cancer. 2017 Jul 11;17(1):478
pubmed: 28693448
Urology. 2013 Feb;81(2):269-75
pubmed: 23374778